Skip to main content
. 2000 Jul 18;97(15):8664–8669. doi: 10.1073/pnas.97.15.8664

Figure 2.

Figure 2

Reversibility of GHB- and baclofen-induced current changes with a specific GABAB antagonist. (A) Control conditions before GHB application. (B) Currents recorded after exposure to 2 mM GHB for 6 min. (C) Recordings obtained after a 2-min superfusion with a solution containing both 2 mM GHB and 500 μM CGP36742. (D) Washout with a 2 mM GHB solution for 5 min. (E) Control conditions before baclofen application. (F) Currents recorded after exposure to 20 μM baclofen for 5 min. (G) Recordings after a 3-min superfusion with a solution containing both 20 μM baclofen and 500 μM CGP36742. Arrows indicate the zero level.